{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444604058
| IUPAC_name = (6''R'',7''S'')-7-([(2''R'',3''S'')-2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-3-hydroxybutanoyl]amino)-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Cefbuperazone.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|cefbuperazone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = IM, IV

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 76610-84-9
| ATC_prefix = J01
| ATC_suffix = DC13
| ATC_supplemental =  
| PubChem = 127527
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1908372
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = T0785J3X40
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03423

|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 113142
|  smiles = CCN1CCN(C(=O)C1=O)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@]2([C@@H]3N(C2=O)C(=C(CS3)CSC4=NN=NN4C)C(=O)O)OC
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C22H29N9O9S2/c1-5-29-6-7-30(16(35)15(29)34)20(39)23-12(10(2)32)14(33)24-22(40-4)18(38)31-13(17(36)37)11(8-41-19(22)31)9-42-21-25-26-27-28(21)3/h10,12,19,32H,5-9H2,1-4H3,(H,23,39)(H,24,33)(H,36,37)/t10-,12+,19+,22-/m0/s1
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = SMSRCGPDNDCXFR-CYWZMYCQSA-N


<!--Chemical data-->
| chemical_formula =  
| C=22 | H=29 | N=9 | O=9 | S=2 
| molecular_weight = 627.65 g/mol
}}

'''Cefbuperazone''' ([[International Nonproprietary Name|INN]]) is a second-generation [[cephalosporin]] antibiotic.<ref>{{Cite journal 
| last1 = Izumi | first1 = K. 
| last2 = Kawazoe | first2 = K. 
| last3 = Mikamo | first3 = H. 
| last4 = Ito | first4 = K. 
| last5 = Tamaya | first5 = T. 
| title = In vivo bacterial regrowth-inhibition effect of cefbuperazone and amikacin in puerperal uterine cavity 
| journal = Journal of chemotherapy (Florence, Italy) 
| volume = 7 Suppl 4 
| pages = 173â€“176 
| year = 1995 
| pmid = 8904147
}}</ref><ref>{{Patent|US|4754030|"Cefbuperazone crystalline triethylamine salt"}}</ref>

==References==
{{reflist}}

{{Cell wall disruptive antibiotics}}

[[Category:Cephalosporin antibiotics]]
[[Category:Tetrazoles]]
[[Category:Piperazines]]


{{antibiotic-stub}}